Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yamaha Motor is a global leader in mobility products such as motorcycles and marine engines. In recent years it has entered the healthcare/life sciences sector through its new US-based subsidiary "Tuning Fork Bio," which provides advanced antibody profiling services using high-density protein microarrays developed with Fukushima Medical University. This enables comprehensive analysis of patient antibodies to support diagnostics, biomarker discovery, personalized medicine decisions, and pharmaceutical research. The company's CELL HANDLER(TM) device automates high-throughput single-cell picking/imaging for R&D labs. While Yamaha itself does not develop drugs or biologics directly nor have a therapeutic pipeline typical of biotech/pharma companies, its subsidiaries are active in providing enabling technologies/platforms to the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yamaha Motor.